[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PTGX":3,"homepage-market-summary":31,"stock-news-PTGX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PTGX","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Protagonist Therapeutics, Inc","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.","141","Newark, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},140.92,137.34,144.1,137.25,138.69,2.23,1.61,927256.937478,16548,141.8213,160.81,64.5,817062.7836011156,79.3,2553,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},18,[176,182,188,194,200,206,212,218,223,228,233,239,244,249,254,259,264,269],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi_AFBVV95cUxQVHBYQjNWeVhNeVJCRWVYLWNJYlpxY19GeFpBZDFoUEU4Zi11WGpfaksxUlNSZ0hFd0hiVTNHWUpnZ0RDTHpqaXRlUW15VmtGNkZVSmRhVGRzYnY3SnFhREN2X3Z0S2s1TEt6ejFmczBUalJ0TUEyTmU0R3lSVlF4RHlCVGhVcEEyQWpJX1p2VjZnWGJqTGQ2OTZWMVBMYk9DOUNUTmxRY0hXMk5HUVdaMGFzalprLTUtc2g2T2NXbVRJR0lvUG0tQnBZT3M5d3pSUkhIbzlxVkxibzl1ODFURks3cWNLRHhCel9RNkRZYmZxcEtDbGx1b1lmS1c?oc=5","Fri, 02 Oct 2026 06:21:59 GMT","Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts MarketBeat","MarketBeat",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"After exercising options, Protagonist Therapeutics (PTGX) CFO sells 58,629 shares under a trading plan. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOUXoxN1VPdjdCVWQyNjdPeHdPNTFnMUo3LUdmQWJGUkV3YVdUNjdEZGJIT0dOV1JSYkJPQmxXempVUjd1V25kU0lUQl9pWUY3M2ItdGtCLTBmTmtoakQ2SzhWdjhVYXlRR0c4SmxYdGloYjFPbVQ4LWxXQy01TVVmdUFyeFFzXzY1cG1KdGRyUUktMmZFYjNEQ0IzUHkxNERXT1JMdjBlMHpxaVRBV1hrYmpNQVJEbXVYVHJyMjNQZw?oc=5","Fri, 02 Oct 2026 20:10:36 GMT","After exercising options, Protagonist Therapeutics (PTGX) CFO sells 58,629 shares under a trading plan. Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Protagonist Therapeutics(PTGX.US) Officer Sells US$8.31 Million in Common Stock - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxOVUFra3FId25OeENyVzBOM0QxVERLQUE0dkppYUdhUHA3QXRDX3JZZ2xpZzZkN1JIUGhESnBvOTdxLUVDLUFzc1dBb2Job2NuMS1McF8zVmZwUGYyYXVMemR0T3paMmNkY21nVDFpVlZIVHFVNkJnUHlBNmZvV25NUTVJT01IVG5wWjEwbHpRQVh6Z1ppSTZURXExdER6OGFkOXpOQUNxcGJ5bHho?oc=5","Fri, 02 Oct 2026 22:28:28 GMT","Protagonist Therapeutics(PTGX.US) Officer Sells US$8.31 Million in Common Stock Moomoo","Moomoo",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Protagonist Therapeutics (PTGX) Could Be 25% Undervalued On Its Royalty Backed Story - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7wFBVV95cUxQV0syc0hCWUNqLVkwMWpTaWxjUTdmbjR6SEMxZ0tDTUxhVDYzcEQyTTBXUm50R3dmWnBqaFZPYXlrZ2t3MG5RdEVlV0pfaE5Ib1RjeEQ1Rm5BLVhkU1JTVkZNSXRYaTBNM2RIMGNRVW5LNjgwQk5KY3FVNThCc3FaRFNJYWNmSnN1cjlpUEhCMVoycHBUZmYtdVI3amJSX29fZUF2X3pIMXIwa0lBRXR4clFOcUIwbkY0YjQyX08wUEl2TktNMGRMVkg2blhKekdIdEVTSy1tNWRQUjBwOUViQm1TS2oyZW9BQnh3Qi1LNNIB9AFBVV95cUxNMVVBalJNSzdWdDhrNkJCRno0RURacVlGX2xnZElYOGJmLTJGUjZlcGZRdHc5Y0Z6S0JvOGdxTFUxd0Y3eE5VTnZCZzkwSEc1dXptbzVOZ21sTS05dHNpZ3R6MDl4S2w3Rl9JNmFGSjNCYnRxdGx3LVB0d2RaOHQ5TE9yc0wwRW1pSXRmVVhCbzdKRTB0V0NOaERJQWVKVEhIWlEySHJhNkZvV1lxWEFLZXZJM0diSElxTkhDeVVQcGZleTJQTVlLdlI0dE5UV3lTWjRSRU9BbXVqTFdDMldPR0ZFenJJTGdnUU5WeTdvU3RjOEdV?oc=5","Sat, 03 Oct 2026 10:23:53 GMT","Protagonist Therapeutics (PTGX) Could Be 25% Undervalued On Its Royalty Backed Story Simply Wall Street","Simply Wall Street",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"PTGX Jan 2027 145.000 call (PTGX270115C00145000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE44SVEzX0dCdlNEX3Q5cVQ1XzRldGRSd051dFo0cTJXZlpSQkVVZ2hWOWNaVFd0azFLQXlzZ1BHbDVoMU04OURvbjVsRDZ5MEdVenVVam9Fd2lyalZGRTBUYllZVUliQQ?oc=5","Thu, 01 Oct 2026 08:22:30 GMT","PTGX Jan 2027 145.000 call (PTGX270115C00145000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxPUzU3VEZRX2NzX0hsOG1zS3MxQkdCNEFvRklKQjRUbXl0ck1CUTZTXzFtaGFNY0MyVkliNC16RC1HaHZkMVJmUnNWUXFHa2FEcE0tWEwzcy1qN2pqQThiWTU1OFNoVmtMS2pEVWRWRko1NGZVUlNYT2FNRF96TjFRQUt1ZU9UdUV4TEd5cnZMdUk2c1lHMExBQUJCbzcxRm5iY3pBUlMtNlNLZlpyeG5VSE1rNnM4SnRPZjRsR0tDa2JCSzg1NUJ6WnlTQk4?oc=5","Mon, 28 Sep 2026 14:45:42 GMT","Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today Benzinga","Benzinga",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"(PTGX) Volatility Zones as Tactical Triggers - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOcVZEaV9HNExjYkNHNmkyVERCZVF1bG0wNzVfWF9vU2NyVzBPVUFMQWRaRzFkbGo0TXI2MHp6bDFZZlRkQmJGb3ZQY3Z3ZnptSW1qZW13eTZ4bHBRdGxTTTIydVRRcWYyNHNPaU9IMmIyWXlfUHJseG0yajkyRGpONEFJamVDcXpMTGJiY2Q3WXFYYXE4Ulh6SXA3d05aOTNlckZwOUdOeV9peFkwTUV0d1Q2Rm1JdWthem1HRkw2TTc?oc=5","Sat, 03 Oct 2026 13:04:01 GMT","(PTGX) Volatility Zones as Tactical Triggers Stock Traders Daily","Stock Traders Daily",{"title":219,"link":220,"pubDate":221,"description":222,"source":187},"Officer Asif Ali plans to sell 58,629 Protagonist Therapeutics (PTGX) shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxOUlNwVXlVV3FDSEdoeUd6RGNlLVNaY19kZmxJbjBLS3JMaEZjbDE3RHpMekp6cU9kYXFzUUhfWEx0dnB4QmxBc0FDeFVGY1VpMy1WV0xrOVJlWWpET2syTzNiUTItZkk1NnAyaGh0VWY1OFRsTng2dWJ0OC1YM2RqeUdOUkgtTGtoRlF1bm0yNEhxWF83bmNMMFNHYTZBek0xZlVtTlBfUlM?oc=5","Wed, 30 Sep 2026 20:20:39 GMT","Officer Asif Ali plans to sell 58,629 Protagonist Therapeutics (PTGX) shares. Stock Titan",{"title":224,"link":225,"pubDate":226,"description":227,"source":181},"Protagonist Therapeutics (PTGX) Insider Trading Activity 2026 - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTFB2eFRXZjdFSF9BQXJReTdCMTVUd3AzWXZkeFhncDJ3LVJIOFFvcjdza1dzYmwwWlp0dVNLbVJLS2R6d3dpb3JnMV9UQ1lEY2J4MUNEbXhROGlmbGVLanpEaXY5cHYxX2prVlBMcjJ3?oc=5","Wed, 30 Sep 2026 07:00:00 GMT","Protagonist Therapeutics (PTGX) Insider Trading Activity 2026 MarketBeat",{"title":229,"link":230,"pubDate":231,"description":232,"source":205},"PTGX Apr 2027 155.000 call (PTGX270416C00155000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFB2bTFQelo0YmF1SXpiNGJLQzd0dU9sN3lWRmtRRmduanlWUGhxc2dwa2dGNWxZQ1ZiR25vRzRKNm8ya0J3WGNzVlRLcjNrT0ZaRDBHWkdOVllwbm8tMGx3cVNpOUk0UQ?oc=5","Fri, 02 Oct 2026 11:58:51 GMT","PTGX Apr 2027 155.000 call (PTGX270416C00155000) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":234,"link":235,"pubDate":236,"description":237,"source":238},"Protagonist Therapeutics stock fell 1.38 percent on October 6 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQUER2eTlQVlljOGdMRnhnUmMzR0JEUUpwZEk0UWk0T2YtTTdudVh4Njgwem9xOEZKOUVVQ0xUT1BkZnRpTWlyejE2bWZvVUo1MzYtb1FBYUItSzJQWEZKRGU1NWthSUFqem5oZnRYZ1JmZUFfbklHNkM2cXcwb2pMd1FsYUwyWkxYRTFwRGhud2QwSVkzbk5FeU9CM01HeWlhaGFqRG1wQmFMZjBUSm1kN3dBQTV3WFFSU2RXcA?oc=5","Tue, 06 Oct 2026 23:35:27 GMT","Protagonist Therapeutics stock fell 1.38 percent on October 6 AD HOC NEWS","AD HOC NEWS",{"title":240,"link":241,"pubDate":242,"description":243,"source":193},"Possible Bearish Signals With Protagonist Therapeutics Insiders Disposing Stock - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPQ1VVbmtnclJBeU9rN290REZENlk4TWtYaHh3dzU2QkxydzUyQXg0TWcwckQ4N3ptY3JSZnNEUjVUY1BCZl9Bd1Mwc3h0VlA5bDhGX2pUZm13VENybzByd0FzMDI3V1RQTjdSSGpWUXgtT3NPUEd3b3d6SzgyWVA3TVJKeVRlRWZsYmVMQ1B4WXpBelY1ajY5Z1dYNU5ZekZrNDFzTy1DSEhTS3N5UUJqZDZvalJIeERiTFpPa05VcjY?oc=5","Tue, 29 Sep 2026 07:00:00 GMT","Possible Bearish Signals With Protagonist Therapeutics Insiders Disposing Stock Moomoo",{"title":245,"link":246,"pubDate":247,"description":248,"source":181},"Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 58,629 Shares of Company Stock - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6gFBVV95cUxNdnNjbDZvdl9KVXlzNVpUcUd5Yk92cHJDNHU3RC1nemhCMUIxNWdRVjJQcUNCR1BzOFRLMlNQUHVwbGVZbGNWSEtELTNCVGJJbTBIYzlKMW1qVWNfcndUcmZnbmpZZFYxMWEyWWhuMi1FNWVwSW5RdnpzeWxKbG1ma01zZkZzaWdNMjdGc3RsQnozbGRmYTRBRnVKcm1qekRCb0NmdW5iMlhTaVlQT2lQQzBTNVVQb3U4czZWYmlFWGg4U1NyUGZiRUFLaHhtWXF3UEk2ZnhCQ0VYSHJtSVBDb2JGRmxjN0h6aEE?oc=5","Fri, 02 Oct 2026 21:23:16 GMT","Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 58,629 Shares of Company Stock MarketBeat",{"title":250,"link":251,"pubDate":252,"description":253,"source":205},"PTGX Jan 2027 145.000 call (PTGX270115C00145000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE5qSjFGV3BPdFBOaktiWHF4MkxEQmhjZXppdjJPb3daZE5LYTFhcldJRG02ZkpxOTNaWXJPY1lSWDlQVHBzUmV0VVlrcU1qVGdwMWo1Q01JSlkwVXV6OTc0cGJxaGxlYlBLWUNzaWJR?oc=5","Thu, 01 Oct 2026 17:15:07 GMT","PTGX Jan 2027 145.000 call (PTGX270115C00145000) Interactive Stock Chart Yahoo! Finance Canada",{"title":255,"link":256,"pubDate":257,"description":258,"source":238},"Protagonist Therapeutics stock gains 1.47 percent on Nasdaq 2026-10-05 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxPZ0Y0TzRxYTFXeDNzeDlPaFMyQXhEWS13ZEVSaEM5WUpCNmc5OXpiLXgzemduRmRyT0ZZT2tCaFFaY0hnSWp6TzRvVXNmQm1vX2dBYzhFZFdnZkd4T1BvLVlfWXVfSXpFNk5EdjBxeXJ0VDBDS1EtOGhKd3dTWUhmZl9RNThMNWJqZGVDM0JKS0tKYkRISVp1LXI0ZloxR2R0OTlaRjVYQlBvbjFwaUhzdGVMMzdia016d1RuMGlsVnZjUW51cmhhOVI1aGoxdw?oc=5","Mon, 05 Oct 2026 17:36:39 GMT","Protagonist Therapeutics stock gains 1.47 percent on Nasdaq 2026-10-05 AD HOC NEWS",{"title":260,"link":261,"pubDate":262,"description":263,"source":205},"PTGX Jan 2027 195.000 call (PTGX270115C00195000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE1TWk1jWkdnR2pWclVUTXFhVWxYNzUxV1lNUUt0MlQ3X3BXZGFhRGVZem5OSWVYVkFteGJ2QWlCQW0zYi1zbWk2N1M5TENWUkNMMDdVenpCcEpBMXIyWkxfOFlZMWo0dHpvTHNxLUx3?oc=5","Sun, 04 Oct 2026 09:42:11 GMT","PTGX Jan 2027 195.000 call (PTGX270115C00195000) Interactive Stock Chart Yahoo! Finance Canada",{"title":265,"link":266,"pubDate":267,"description":268,"source":238},"Protagonist Therapeutics stock gets USD 300.0 million buyback approval - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxQa2FVeHBXd2NDN05Oa1o3UUlxVXFFbXREemlfcEdxdmZKSktUTjNHZ3VxOHZSMHBsbF9iMmdJWFlZb2VDenU5eVBlTTdhVTNGR0dmRWlhTjRjNmU2OS13RFhyRDFyT1Z1cF9ZVzJUU3pscUM1T1NHQ2RGcXExSHBuRDlVYTlWS2VqS2pueFp4QmV2SWMyM0hXbEJPZmY2U212SXhfQ3FSUXJBbmh0aWlCQkFnZW5wTEE0S2hzY21GOThORUNnM3lXZQ?oc=5","Tue, 29 Sep 2026 12:03:31 GMT","Protagonist Therapeutics stock gets USD 300.0 million buyback approval AD HOC NEWS",{"title":270,"link":271,"pubDate":272,"description":273,"source":274},"PTGX270115P00160000 Interactive Stock Chart | PTGX Jan 2027 160.000 put Stock - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTE11QXBWRlJKajZCT2M1ZEtvYU5fMmdCaTZvek04OGlKUFRncTRZNktLSTdiQWF3QVVHWGVFU3ZyRFQ5SXVETFplb3Z4OWlxOUhHN19tT2ZOLWdhX3o1bGVhVw?oc=5","Fri, 02 Oct 2026 21:09:38 GMT","PTGX270115P00160000 Interactive Stock Chart | PTGX Jan 2027 160.000 put Stock Yahoo Finance","Yahoo Finance"]